Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma

International Archives of Medicine

Volumn 2, Issue 1, 2009, Pages

  Maximous, Doaa W ^a   Abdel Wanis, Mostafa E ^a   El Sayed, Mohammed I ^a,b   Abd Elsayed, Alaa A ^b  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LIVER METASTASIS; LIVER TOXICITY; MALE; NAUSEA; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; RADIATION DOSE FRACTIONATION; THROMBOCYTOPENIA; VOMITING;

EID: 77953401842     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-2-7     Document Type: Article

References (19)

1. Current management of locally advanced pancreatic cancer. V Maheshwari J Moser, Nature Clinical Practice Gastroenterology & Hepatology 2005 2 356 364 10.1038/ncpgasthep0240 16265403
2. Chemoradiation for ductal pancreatic carcinoma: Principles of combining chemotherapy with radiation, definition of target volume and radiation dose. R Wilkowski M Thoma H Weingandt E Dühmke V Heinemann, JOP 2005 6 3 216 230 15883472
3. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. JB Ammori LM Colletti MM Zalupski FE Eckhauser JK Greenson J Dimick TS Lawrence CJ McGinn, Journal of Gastrointestinal Surgery 2003 7 6 766 72 10.1016/S1091-255X(03)00113-6 13129554
4. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. R White C Lee M Anscher M Gottfried R Wolff M Keogan T Pappas H Hurwitz D Tyler, Annals of Surgical Oncology 1999 6 1 38 45 10.1007/s10434-999-0038-z 10030414
5. Epidemiology of cancer. OH El-Hattab MA Nouh, NCI El-Bolkainy, MN: Topographic pathology of cancer 1998
6. Epidemiology of and risk factors for pancreatic cancer. EL Gold SB Goldi, Surg Oncol Clin N Am 1998 7 67 91 9443987
7. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil: A first step to neoadjuvant treatment? HG Smeenk SM de Castro JJ Jeekel G Kazemier OR Busch L Incrocci J Erdmann WC Hop DJ Gouma CH van Eijck, Digestive Surgery 2005 22 191 197 10.1159/000087973 16137997
8. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. JP Hoffman JL Weese LJ Solin P Engstrom P Agarwal LW Barber MC Guttmann S Litwin H Salazar BL Eisenberg, Am J Surg 1995 169 1 71 7 10.1016/S0002-9610(99)80112-3 7818001
9. Preoperative chemoradiation in locally advanced pancreatic carcinoma: A phase II study. TB Brunner GG Grabenbauer S Kastl O Herrmann U Baum R Fietkau P Klein W Bautz T Schneider W Hohenberger R Sauer, Onkologie 2000 23 436 442 10.1159/000027214 11441238
10. Small pancreatic tumors: Is size an indication of curability? HA Reber, Journal of Hepato-Biliary-Pancreatic Surgery 1995 2 4 384 386 10.1007/BF02349254
11. Concurrent chemoradiotherapy for advanced pancreatic cancer: 1000 mg/m2 gemcitabine can be administered using limited field radiotherapy. H Yamazaki K Nishiyama M Koizumi E Tanaka T Ioka H Uehara H Iishi A Nakaizumi H Ohigashi O Ishikawa, Strahlenther Oncol 2007 183 6 301 6 10.1007/s00066-007-1641-1
12. Treatment of resectable and locally advanced pancreatic cancer. Lee Moffitt Cancer Center and Research Institute, Cancer control 2000 7 5 428 436 11000612
13. Combined 5-flurouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. CG Mortel DS Childs RJ Reitemeier MY Colby MA Holbrook Jr, Lancet 1969 2 865 7 10.1016/S0140-6736(69)92326-5 4186452
14. Therapy of localised unresectable pancreatic carcinoma: a randomised comparison of high dose ((6000 rads)) radiation alone, moderate dose (4000 rads) radiation + 5-FU and high dose radiation + 5-FU. Gastrointestinal Tumour Study Group, Cancer 1981 48 1705 10 10.1002/1097-0142(19811015)48:8<1705::AID- CNCR2820480803>3.0.CO;2-4 7284971
15. Concurrent chemoradiotherapy treatment (CCRT) of locally advanced pancreatic cancer (LAPC): gemcitabine (GEM) versus 5-flurouracil (5-FU) [abstract]. CP Li Y Chao KH Chi WK Chan HC Teng RC Lee, Proc Ann Meet Am Soc Clin Oncol 2003 22 19a
16. Survival benefit of chemotherapy treatment in advanced pancreatic cancer: a meta-analysis [abstract]. MC Fung H Ishiguro S Takayama T Morizane S Adachi T Skata, Proc Ann Meet Am Soc Clin Oncol 2003 22 288a 1155
17. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? HJ Kim K Czischke MF Brennan KC Conlon, J Gastrointest Surg 2002 6 5 763 9 10.1016/S1091-255X(02)00017-3 12399067
18. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: Analysis of perioperative outcome and survival. P Massucco L Capussotti A Magnino E Sperti M Gatti A Muratore E Sgotto P Gabriele M Aglietta, Annals of Surgical Oncology 2006 13 1201 1228 10.1245/s10434-006-9032-x 16955382
19. Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. S Takai S Satoi H Yanagimoto H Toyokawa K Takahashi N Terakawa H Araki Y Matsui M Sohgawa Y Kamiyama, Pancreas 2008 36 1 26 32 10.1097/mpa.0b013e31814b229a 18192877